Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors

Nature Methods

Volumn 7, Issue 11, 2010, Pages 929-935

  Anliker, Brigitte ^a   Abel, Tobias ^a   Kneissl, Sabrina ^a   Hlavaty, Juraj ^b   Caputi, Antonio ^c   Brynza, Julia ^a   Schneider, Irene C ^a   Münch, Robert C ^a   Petznek, Helga ^b   Kontermann, Roland E ^d   Koehl, Ulrike ^e   Johnston, Ian C D ^f   Keinänen, Kari ^g   Müller, Ulrike C ^h   Hohenadl, Christine ^b   Monyer, Hannah ^c   Cichutek, Klaus ^a   Buchholz, Christian J ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c The Department of Neurology   (Germany)

^d UNIVERSITY OF STUTTGART   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f MILTENYI BIOTEC GMBH   (Germany)

^g UNIVERSITY OF HELSINKI   (Finland)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD20 ANTIGEN; CRE RECOMBINASE; ENDOGLIN; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 4; LENTIVIRUS VECTOR; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CEREBELLUM; DNA MODIFICATION; ENDOTHELIUM CELL; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HIPPOCAMPUS; LYMPHOCYTE; MIXED CELL CULTURE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD20; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HIPPOCAMPUS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; NEURONS; PEPTIDES; RECEPTORS, AMPA;

MUS; VESICULAR STOMATITIS VIRUS;

EID: 78049345098     PISSN: 15487091     EISSN: 15491676     Source Type: Journal    
DOI: 10.1038/nmeth.1514     Document Type: Article

References (38)

1. Cockrell, A.S. & Kafri, T. Gene delivery by lentivirus vectors. Mol. Biotechnol. 36, 184-204 (2007).
2. Singer, O. & Verma, I.M. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr. Gene Ther. 8, 483-488 (2008).
3. Naldini, L. Medicine. A comeback for gene therapy. Science 326, 805-806 (2009).
4. Frecha, C., Szecsi, J., Cosset, F.L. & Verhoeyen, E. Strategies for targeting lentiviral vectors. Curr. Gene Ther. 8, 449-460 (2008).
5. Wong, L.F. et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum. Gene Ther. 17, 1-9 (2006).
6. Meunier, A. & Pohl, M. Lentiviral vectors for gene transfer into the spinal cord glial cells. Gene Ther. 16, 476-482 (2009).
7. Buchholz, C.J., Muhlebach, M.D. & Cichutek, K. Lentiviral vectors with measles virus glycoproteins\-dream team for gene transfer? Trends Biotechnol. 27, 259-265 (2009).
8. Morizono, K. et al. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat. Med. 11, 346-352 (2005).
9. Yang, L., Bailey, L., Baltimore, D. & Wang, P. Targeting lentiviral vectors to specifc cell types in vivo. Proc. Natl. Acad. Sci. USA 103, 11479-11484 (2006).
10. Nakamura, T. et al. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat. Biotechnol. 23, 209-214 (2005).
11. Funke, S. et al. Targeted cell entry of lentiviral vectors. Mol. Ther. 16, 1427-1436 (2008).
12. Funke, S. et al. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity. Gene Ther. 16, 700-705 (2009).
13. Fonsatti, E. & Maio, M. Highlights on endoglin (CD105): from basic fndings towards clinical applications in human cancer. J. Transl. Med. 2, 18 (2004).
14. Shmelkov, S.V., St Clair, R., Lyden, D. & Rafi, S. AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 37, 715-719 (2005).
15. Mizrak, D., Brittan, M. & Alison, M.R. CD133: molecule of the moment. J. Pathol. 214, 3-9 (2008).
16. Yanagi, Y., Takeda, M., Ohno, S. & Hashiguchi, T. Measles virus receptors. Curr. Top. Microbiol. Immunol. 329, 13-30 (2009).
17. Baum, C., Hegewisch-Becker, S., Eckert, H.G., Stocking, C. & Ostertag, W. Novel retroviral vectors for effcient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69, 7541-7547 (1995).
18. Pasternack, A. et al. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor channels lacking the N-terminal domain. J. Biol. Chem. 277, 49662-49667 (2002).
19. Carman, C.V. & Springer, T.A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167, 377-388 (2004).
20. Hess, K.L. et al. Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp. Cell Res. 236, 404-411 (1997).
21. Ozawa, S., Kamiya, H. & Tsuzuki, K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54, 581-618 (1998).
22. Sprengel, R. Role of AMPA receptors in synaptic plasticity. Cell Tissue Res. 326, 447-455 (2006).
23. Fuchs, E.C. et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53, 591-604 (2007).
24. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21, 70-71 (1999).
25. Rolls, M.M., Webster, P., Balba, N.H. & Rose, J.K. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 79, 497-506 (1994).
26. Kim, Y.S. et al. Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins. Mol. Ther. 18, 1310-1317 (2010).
27. Pariente, N., Mao, S.H., Morizono, K. & Chen, I.S. Effcient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J. Gene Med. 10, 242-248 (2008).
28. Lang, P. et al. Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br. J. Haematol. 124, 72-79 (2004).
29. Singh, S.K. et al. Identifcation of human brain tumour initiating cells. Nature 423, 396-401 (2004).
30. Brown, B.D. & Naldini, L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10, 578-585 (2009).
31. Jespersen, L.K., Kuusinen, A., Orellana, A., Keinanen, K. & Engberg, J. Use of proteoliposomes to generate phage antibodies against native AMPA receptor. Eur. J. Biochem. 267, 1382-1389 (2000).
32. Volkel, T., Muller, R. & Kontermann, R.E. Isolation of endothelial cell-specifc human antibodies from a novel fully synthetic scFv library. Biochem. Biophys. Res. Commun. 317, 515-521 (2004).
33. Demaison, C. et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodefciency (correction of immunodefciency) virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13, 803-813 (2002).
34. Sun, Y., Finger, C., Alvarez-Vallina, L., Cichutek, K. & Buchholz, C.J. Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth. Cancer Gene Ther. 12, 900-912 (2005).
35. Steinbach, J.P. et al. Hypersensitivity to seizures in beta-amyloid precursor protein defcient mice. Cell Death Differ. 5, 858-866 (1998).
36. Liehl, B. et al. Simian immunodefciency virus vector pseudotypes differ in transduction effciency and target cell specifcity in brain. Gene Ther. 14, 1330-1343 (2007).
37. Fuchs, E.C. et al. Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. Proc. Natl. Acad. Sci. USA 98, 3571-3576 (2001).
38. Cetin, A., Komai, S., Eliava, M., Seeburg, P.H. & Osten, P. Stereotaxic gene delivery in the rodent brain. Nat. Protoc. 1, 3166-3173 (2006).